يعرض 1 - 6 نتائج من 6 نتيجة بحث عن '"Memorial Sloan–Kettering Cancer Center risk"', وقت الاستعلام: 0.93s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Outcomes According to MSKCC Risk Score with Focus on the Intermediate-Risk Group in Metastatic Renal Cell Carcinoma Patients Treated with First-Line Sunitinib: A Retrospective Analysis of 2390 Patients

    المؤلفون: Ondrej Fiala, Jindrich Finek, Alexandr Poprach, Bohuslav Melichar, Jindrich Kopecký, Milada Zemanova, Katerina Kopeckova, Tomas Mlcoch, Tomas Dolezal, Lenka Capkova, Tomas Buchler

    المصدر: Cancers, Vol 12, Iss 4, p 808 (2020)

    مصطلحات موضوعية: renal cell carcinoma, Memorial Sloan–Kettering Cancer Center risk, sunitinib, first line, outcome, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    وصف الملف: electronic resource

    Relation: https://www.mdpi.com/2072-6694/12/4/808; https://doaj.org/toc/2072-6694

    URL الوصول: https://doaj.org/article/9f7a13692e81478185495db26714f25d

    Find this article in full text from ProQuest Full Text Finder
    أضف إلى المفضلة
  2. 2
    Outcomes According to MSKCC Risk Score with Focus on the Intermediate-Risk Group in Metastatic Renal Cell Carcinoma Patients Treated with First-Line Sunitinib: A Retrospective Analysis of 2390 Patients

    المؤلفون: T. Dolezal, Milada Zemanova, Ondrej Fiala, Lenka Capkova, Jindrich Kopecký, Jindrich Finek, T. Mlcoch, Tomas Buchler, Bohuslav Melichar, Alexandr Poprach, Katerina Kopeckova

    المصدر: Cancers
    Volume 12
    Issue 4
    Cancers, Vol 12, Iss 808, p 808 (2020)

    مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, renal cell carcinoma, First line, sunitinib, first line, lcsh:RC254-282, Article, 03 medical and health sciences, 0302 clinical medicine, Renal cell carcinoma, Internal medicine, Memorial Sloan–Kettering Cancer Center risk, Retrospective analysis, Medicine, 030212 general & internal medicine, Risk factor, Framingham Risk Score, business.industry, Sunitinib, Cancer, Retrospective cohort study, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, 3. Good health, 030220 oncology & carcinogenesis, outcome, business, medicine.drug

    وصف الملف: application/pdf

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d7b3a7a8e165a452646dfff1858b0cf
    https://zenodo.org/record/5464066

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية

    لا يتم عرض هذه النتيجة على الضيوف.

    View this record from ISI Web of Science
    أضف إلى المفضلة
  4. 4
    دورية أكاديمية

    لا يتم عرض هذه النتيجة على الضيوف.

    View record in Scopus
    أضف إلى المفضلة
  5. 5
    دورية أكاديمية

    لا يتم عرض هذه النتيجة على الضيوف.

    View record in Scopus
    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    Progression-free survival of first-line treatment with molecular-targeted therapy may be a meaningful intermediate endpoint for overall survival in patients with metastatic renal cell carcinoma.

    المؤلفون: Furubayashi N; Department of Urology, National Kyushu Cancer Center, Fukuoka 811-1395, Japan., Negishi T; Department of Urology, National Kyushu Cancer Center, Fukuoka 811-1395, Japan., Yamashita T; Department of Urology, National Kyushu Cancer Center, Fukuoka 811-1395, Japan., Kusano S; Department of Urology, National Kyushu Cancer Center, Fukuoka 811-1395, Japan., Taguchi K; Department of Pathology, National Kyushu Cancer Center, Fukuoka 811-1395, Japan., Shimokawa M; Institute for Clinical Research, National Kyushu Cancer Center, Fukuoka 811-1395, Japan., Nakamura M; Department of Urology, National Kyushu Cancer Center, Fukuoka 811-1395, Japan.

    المصدر: Molecular and clinical oncology [Mol Clin Oncol] 2017 Sep; Vol. 7 (3), pp. 454-460. Date of Electronic Publication: 2017 Jul 13.

    نوع المنشور: Journal Article

    بيانات الدورية: Publisher: Spandidos Publications UK Ltd Country of Publication: England NLM ID: 101613422 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2049-9450 (Print) Linking ISSN: 20499450 NLM ISO Abbreviation: Mol Clin Oncol Subsets: PubMed not MEDLINE

    Find this article in full text from ProQuest Full Text Finder
    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء